MedPath

Sensory Stimulation Effect on Movement Speed in Patients With Parkinson Disease

Not Applicable
Completed
Conditions
Parkinson Disease
Interventions
Other: Aponeurotic stimulation (the diacutaneous fibrolysis method)
Other: Placebo stimulation
Registration Number
NCT01544738
Lead Sponsor
Université Libre de Bruxelles
Brief Summary

Movement slowness (bradykinesia) is one of the main motor symptoms in Parkinson Disease (PD). Several studies have shown that patients with PD exhibit slowness because they are unable to modulate, in an optimal way, the velocity of voluntary motor acts not induced by external stimulation. Indeed, these patients have difficulties to integrate multi-sensorial information, mainly proprioception.

The investigators investigated changes in shoulder velocity during pointing movements by patients with PD after stimulation of soft tissues (aponeurosis) of upper limb muscles. The stimulation consisted of manipulating, with a hook (the diacutaneous fibrolysis method), the aponeurotic tissues enrobing the heads of the upper limb muscles. This technique has previously been shown to decrease passive tension and the tendon reflex response of the manipulated muscle group. The investigators hypothesis is that aponeurotic manipulation of shoulder muscles therefore creates a modification in the proprioceptive information, which in return temporarily decreases the bradykinesia of shoulder movements.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
11
Inclusion Criteria
  • Clinical diagnosis of Parkinson Disease
Exclusion Criteria
  • Patients with a limitation in the shoulder range of motion necessary to perform pointing movements

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Aponeurotic stimulation groupAponeurotic stimulation (the diacutaneous fibrolysis method)The stimulation consisted of manipulating, with a hook (the diacutaneous fibrolysis method), the aponeurotic tissues enrobing the heads of the trunk and upper limb muscles.
Placebo stimulation groupPlacebo stimulationPlacebo stimulation (PS) consisted of manipulating the skin along the same paths over the trunk, shoulder and arm muscles that were the targets for treatment in the Aponeurotic stimulation group.
Primary Outcome Measures
NameTimeMethod
3D kinematic movement parameters and upper limb muscles electromyographic activationParticipants will be followed for the duration of the clinical test (2 weeks)
Secondary Outcome Measures
NameTimeMethod
Unified Parkinson's Disease Rating Scale (UPDRS)Participants will be followed for the duration of the clinical test (2 weeks)

Trial Locations

Locations (1)

ULB-FSM Laboratory of neurophysiology and movement biomechanics

🇧🇪

Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath